Sertraline in the treatment of anxiety disorders. - Wikidata - wikimedia - TriplyDB

Sertraline in the treatment of anxiety disorders.

Sertraline in the treatment of anxiety disorders.

http://www.wikidata.org/entity/Q33914087

about

PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD Inhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations.Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety.

P2860

Q30474822-14B6DFE3-A694-4DF4-ACA4-1FEAE3917562 Q36571936-7E7684C7-15B0-474D-84AF-87375238B546 Q38120061-92E55F0B-6902-448C-813B-6F60C536FED2

P2860

Sertraline in the treatment of anxiety disorders.

http://www.wikidata.org/entity/Q33914087

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Sertraline in the treatment of anxiety disorders.

@ast

Sertraline in the treatment of anxiety disorders.

@en

type

label

Sertraline in the treatment of anxiety disorders.

@ast

Sertraline in the treatment of anxiety disorders.

@en

prefLabel

Sertraline in the treatment of anxiety disorders.

@ast

Sertraline in the treatment of anxiety disorders.

@en

P1433

Q33914087-C791ADDF-E0B3-4F85-A441-2E1CCCD93DE3

P1476

Q33914087-B3FE06D1-F9E1-4C79-BF55-F93104516B73

P2093

Q33914087-372906CE-6ADB-4E30-A6E0-91253FF3BDFF

P2860

Q33914087-13FC0E9F-4819-4A11-B397-60AA350BE805

Q33914087-34980F29-BC86-46D4-8412-DCD192F1AEC2

Q33914087-4716B09F-EB9E-410F-AC46-9A7374F66DC6

Q33914087-7F879A19-0E60-41C2-BE10-9DABDE2525DB

Q33914087-80C1A292-13E8-4C99-B590-7E04FA1503C8

Q33914087-85400FB9-8E10-43AE-8E4A-5E96C9361B6B

Q33914087-9E4056A5-9AA3-456F-8469-F6ED93B2D535

Q33914087-A412ECA0-0902-493A-B4F0-6A904D6491BA

Q33914087-B6543695-DC8C-4B7A-A3C9-61FA5FCE95FF

Q33914087-CD47D0E0-A76C-4150-9D19-824924222A47

P304

Q33914087-7DE106FD-E49A-4DFA-900F-8B22DB88B346

P31

Q33914087-A1986C91-1A92-4791-A702-BF21068A39A6

P356

Q33914087-41F91F19-DB96-4EDE-A9A0-696772C3EE4D

P433

Q33914087-8D924C6C-D2A2-405C-A034-BF8FD780E376

P478

Q33914087-56D2AAF5-6210-4177-BE3F-65E27D98FB5F

P577

Q33914087-75B63BBE-E8AA-4734-8B5F-8538FA95473E

P698

Q33914087-F9A5D83A-98E6-4A60-B0BF-8D0E7CCC9DDE

P356

1520-6394(2000)11:4%3C139::AID-DA1%3E3.0.CO;2-C

P1433

Depression and Anxiety

P1476

Sertraline in the treatment of anxiety disorders.

@en

P2093

Hirschfeld RM

http://www.w3.org/2001/XMLSchema#string

P2860

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

Sertraline in social phobia.

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

P304

139-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10945134

http://www.w3.org/2001/XMLSchema#string